Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,558,172
-$3,044,118 QoQ
Shares Held
260,543
+16.1% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Mar 31, 2026CallValue
$8,362,700
CallShares
173,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. GPCR ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in GPCR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,362,700 | 173,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $12,558,172 | 260,543 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,066,925 | 173,500 | Call | Defined | 2026-03-25 | |
| 2025-12-31 | $15,602,290 | 224,332 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $14,123,088 | 504,396 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,566,408 | 220,174 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $605,850 | 35,000 | Call | Defined | 2025-06-27 | |
| 2025-03-31 | $5,615,969 | 324,435 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $15,807,298 | 582,865 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $31,284,572 | 712,795 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $583,737 | 13,300 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $26,796,395 | 682,363 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,230,039 | 448,671 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,434,478 | 427,735 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,601,651 | 71,433 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||